Search results (14)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
New guidelines published for monitoring IBD patients to prevent bowel cancer
1 May 2025
Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
Dr David Church awarded Senior Cancer Research Fellowship from Cancer Research UK
21 March 2025
David’s research will focus on immune dysregulation in colorectal and endometrial pre-cancers and cancers.
Predicting Response to Rectal Cancer Treatment through the S:CORT consortium
5 December 2024
Recent research from the S:CORT team spanning three publications has identified key biomarkers and treatment strategies that predict and enhance effectiveness of radiotherapy in rectal cancer treatment.
OCION Funding Scheme: In conversation with David Church and Luciana Gneo
10 May 2024
The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology. We sat down with 2023 awardees, David Church and Luciana Gneo, to discuss what research the fund will enable them to carry out.
Crowd-sourcing approach assesses current methods for improved automated detection and boundary mapping of colorectal cancer precursors
5 February 2024
A computer vision challenge was set to objectively quantify the generalisability of polyp detection and mapping algorithms, and challenge participants to innovate novel methods.
AI-based method provides insights for predicting colorectal cancer outcomes
2 February 2024
The largest multiparameter immunoprofiling study in cancer to date has suggested an underappreciated role of a subset of immune cells in determining the risk of bowel cancer relapse after surgery.
What Matters Most to people with colorectal cancer? Oxford Cancer to host workshop on patient priorities.
21 November 2023
Oxford Cancer is committed to supporting research that responds to the needs of people with cancer. We are working with groups of patients with different cancers to identify the ‘Top Ten’ issues that matter most to them. These lists of priorities will be shared with our research colleagues.
Research confirms important differences in colorectal cancer patients with a history of Inflammatory Bowel Disease
12 December 2022
IBD-associated colorectal cancers were found to occur in younger patients and have worse outcomes. Researchers call for urgent improvement of early detection methods to provide more risk-based and personalised care.
Tool to detect cancer stem cell make-up in intestinal tumours
5 August 2022
The Leedham lab have developed a new tool that assesses the relative enrichment of two main types of cancer stem cells in colorectal cancer, which may help to guide therapy selection in the future.
FOCUS4: a flagship trial in colorectal cancer
20 September 2021
Professor Tim Maughan outlines the flagship work of the FOCUS4 trials, whose results were presented this weekend at the European Society of Medical Oncology (ESMO) annual meeting
Eoghan Mulholland awarded colorectal cancer fellowship
1 June 2021
As part of UK Pride month, we are spotlighting the work of cancer researcher and University LGBTQ+ Representative Dr Eoghan Mulholland
Bowel cancer patients going undiagnosed due to COVID distruption
15 January 2021
A new study led by the University of Oxford has found that since the first coronavirus lockdown the number of people diagnosed with bowel cancer in England has fallen sharply, with a deficit persisting up to October 2020.
IL-22 pathway linked to poor prognosis in colon cancer
21 August 2020
Research shows how IL-22 interacts with KRAS mutant tumours to promote excessive growth in colorectal cancer
New digital classification method using AI developed for colorectal cancer
14 July 2020
A new study from S:CORT demonstrates an easy, cheap way to determine colorectal cancer molecular subtype using AI deep-learning digital pathology technology